Statement from FDA Commissioner Scott Gottlieb, M.D., and Director of FDA ’s Center for Biologics Evaluation and Research Peter Marks, M.D., Ph.D., cautioning consumers against receiving young donor plasma infusions that are promoted as unproven treatment for varying conditions

FDA statement cautioning consumers against receiving young donor plasma infusions that are promoted as unproven treatment for varying conditions

Source: Food and Drug Administration - February 19, 2019 Category: American Health Source Type: news